A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.
NCT02752776
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1660
Enrollment
INDUSTRY
Sponsor class
Conditions
Plaque Psoriasis
Interventions
DRUG:
Secukinumab
Sponsor
Novartis Pharmaceuticals